Novartis CEO: We’re moving toward filing Covid drug from Molecular Partners with FDA

0
5


Novartis CEO Vas Narasimhan sits down with CNBC’s Meg Tirrell and the ‘Squawk on the Street’ team to discuss the company’s latest Covid-19 treatment, which it licensed from Molecular Partners.

See also  Trump sticks to rallies as COVID-19 roars back